antihyperlactemics , such as dichloroacetate , may therefore provide a new therapeutic approach to minimizing myelin degeneration in multiple sclerosis and in other cns disorders characterized by inflammatory demyelination .
C0026769
multiple sclerosis
C0007682
cns disorders